These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of Hepatic Bile Acid Uptake by Myrcludex B Promotes Glucagon-Like Peptide-1 Release and Reduces Obesity. Donkers JM, Roscam Abbing RLP, van Weeghel M, Levels JHM, Boelen A, Schinkel AH, Oude Elferink RPJ, van de Graaf SFJ. Cell Mol Gastroenterol Hepatol; 2020 Jan; 10(3):451-466. PubMed ID: 32330730 [Abstract] [Full Text] [Related]
5. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. Baghdasaryan A, Fuchs CD, Österreicher CH, Lemberger UJ, Halilbasic E, Påhlman I, Graffner H, Krones E, Fickert P, Wahlström A, Ståhlman M, Paumgartner G, Marschall HU, Trauner M. J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078 [Abstract] [Full Text] [Related]
6. Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice. Slijepcevic D, Kaufman C, Wichers CG, Gilglioni EH, Lempp FA, Duijst S, de Waart DR, Elferink RP, Mier W, Stieger B, Beuers U, Urban S, van de Graaf SF. Hepatology; 2015 Jul; 62(1):207-19. PubMed ID: 25641256 [Abstract] [Full Text] [Related]
7. Decreased Na+-dependent taurocholate uptake and low expression of the sinusoidal Na+-taurocholate cotransporting protein (Ntcp) in livers of mdr2 P-glycoprotein-deficient mice. Koopen NR, Wolters H, Voshol P, Stieger B, Vonk RJ, Meier PJ, Kuipers F, Hagenbuch B. J Hepatol; 1999 Jan; 30(1):14-21. PubMed ID: 9927146 [Abstract] [Full Text] [Related]
12. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice. Kunst RF, de Waart DR, Wolters F, Duijst S, Vogels EW, Bolt I, Verheij J, Beuers U, Oude Elferink RPJ, van de Graaf SFJ. JHEP Rep; 2022 Nov; 4(11):100573. PubMed ID: 36160754 [Abstract] [Full Text] [Related]
13. Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis. Kunne C, de Graaff M, Duijst S, de Waart DR, Oude Elferink RP, Paulusma CC. Lab Invest; 2014 Oct; 94(10):1103-13. PubMed ID: 25068656 [Abstract] [Full Text] [Related]
14. The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics. Blank A, Eidam A, Haag M, Hohmann N, Burhenne J, Schwab M, van de Graaf S, Meyer MR, Maurer HH, Meier K, Weiss J, Bruckner T, Alexandrov A, Urban S, Mikus G, Haefeli WE. Clin Pharmacol Ther; 2018 Feb; 103(2):341-348. PubMed ID: 28543042 [Abstract] [Full Text] [Related]
15. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S. J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872 [Abstract] [Full Text] [Related]
16. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Stieger B. Handb Exp Pharmacol; 2011 Apr; (201):205-59. PubMed ID: 21103971 [Abstract] [Full Text] [Related]
17. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity. Guo YX, Xu XF, Zhang QZ, Li C, Deng Y, Jiang P, He LY, Peng WX. Toxicol Mech Methods; 2015 Apr; 25(5):382-7. PubMed ID: 25886055 [Abstract] [Full Text] [Related]
18. Regulation of plasma membrane localization of the Na+-taurocholate cotransporting polypeptide (Ntcp) by hyperosmolarity and tauroursodeoxycholate. Sommerfeld A, Mayer PG, Cantore M, Häussinger D. J Biol Chem; 2015 Oct 02; 290(40):24237-54. PubMed ID: 26306036 [Abstract] [Full Text] [Related]
19. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis. Gartung C, Matern S. Yale J Biol Med; 1997 Oct 02; 70(4):355-63. PubMed ID: 9626756 [Abstract] [Full Text] [Related]
20. Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B. Zhao K, Liu S, Chen Y, Yao Y, Zhou M, Yuan Y, Wang Y, Pei R, Chen J, Hu X, Zhou Y, Zhao H, Lu M, Wu C, Chen X. Emerg Microbes Infect; 2018 Nov 21; 7(1):186. PubMed ID: 30459339 [Abstract] [Full Text] [Related] Page: [Next] [New Search]